Big pharma, Biotech, Partnering, Pharma

Diaxonhit seals biotech deals with Boehringer Ingelheim for oncology targets

Posted on 04 September 2013

Tags: , , , ,

Diaxonhit forms biotech deals by entering into a research service agreement with big pharma Boehringer Ingelheim for the discovery and characterization of novel splice variants that have the potential to be therapeutic targets for oncology.

Through the agreement Boehringer Ingelheim secures an option to acquire the rights to research, develop and commercialize, any targets identified using Diaxonhit’s patented SpliceArray discovery platform, with the aim of adding further to its comprehensive research programme to develop innovative new cancer drugs.

Diaxonhit will apply its expertise and target discovery platform, built upon its genome-wide SpliceArray technology, to identify splice variants that are expressed in cancer tissue.

These variants will be analyzed using a unique workflow tailored to rapidly identify and characterize novel epitope targets suitable for antibody-based therapeutic development.

Financial terms were not disclosed.

For further deal information visit Current Agreements (subscription required)


Read: more on Boehringer Ingelheim company profile, recent partnering, M&A and financing news and articles

Report: Oncology Partnering Terms and Agreements

Report: Partnering Deals and Alliances with Baxter Healthcare

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply